818
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant)

, , , , , , & show all
Pages 3523-3525 | Received 06 Jul 2020, Accepted 22 Aug 2020, Published online: 09 Sep 2020
 

Author contributions

MB has the original idea to report the case and treatment purposes and she coordinated the working group. BF, FF, EC and EC managed the patient; VS and AS managed the patient and wrote the paper; AS wrote the paper. All authors revised and approved the final version of the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.